발 및 발목용 기기 시장 규모, 점유율 및 동향 분석 보고서 : 용도별, 지역별, 부문 예측(2025-2033년)

Foot And Ankle Devices Market Summary

The global foot and ankle devices market size was estimated at USD 4.88 billion in 2024 and is projected to reach USD 9.21 billion by 2033, growing at a CAGR of 7.35% from 2025 to 2033. Factors such as the rising geriatric population, the urgent need for user-centric foot & ankle devices, the rising demand for minimally invasive surgical procedures, the increasing use of advanced technologies, such as AI & robotics, and the growing prevalence of target diseases, such as osteoporosis, fuel the market growth.

According to Haleon HealthPartner, an ankle sprain is the most frequent injury globally. Around 628,000 sprains happen annually, and 40% of sprain and strain injuries are caused by playing football. The growing career opportunities in sports and the increasing popularity of athletic pursuits are contributing significantly to the growth of the foot and ankle devices industry. As more individuals, especially children and adolescents, engage in sports, the incidence of sports-related injuries is on the rise. According to a Safe Kids Worldwide survey, a young athlete visits a hospital emergency room for a sports-related injury every 25 seconds, with ankle injuries accounting for 15% and knee injuries for 9% of these cases. This alarming trend indicates a pressing need for effective treatment solutions, driving demand for orthopedic devices, particularly those focused on the foot and ankle.

The increasing adoption of minimally invasive treatments is a key market growth driver, as patients and healthcare providers recognize the advantages these techniques offer over traditional open surgeries. Minimally invasive foot and ankle surgeries involve smaller incisions, reduced pain, shorter hospital stays, faster wound healing, and lower risk of complications, making them a preferred option for patients and surgeons. Procedures such as arthroscopy and minimally invasive total joint replacement enable surgeons to perform complex repairs with minimal disruption to surrounding tissues. Such factors are expected to drive the market growth over the forecast period.

Moreover, key players are adopting various strategic initiatives, such as collaborations, signing new partnership agreements, mergers & acquisitions, and geographic expansions, to strengthen their services and gain a competitive advantage over other companies. For instance, in August 2024, DePuy Synthes, part of Johnson and Johnson MedTech, launched the TriLEAP Lower Extremity Anatomic Plating System. This innovative system features low-profile titanium plates specifically designed for foot & ankle surgeons. The plates are tailored for various trauma and reconstructive procedures in the forefoot and midfoot, applicable for both adults and adolescents. The TriLEAP System is intended to stabilize and fuse bones and bone fragments.

Global Foot And Ankle Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country level and provides an analysis of industry trends in each of the sub segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the foot and ankle devices market report based on application and region:

• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Foot and Ankle (F&A) Trauma
  • Ankle Trauma
  • Fibula fixation and syndesmosis repair systems
  • Talus and calcaneus trauma plates
  • Pilon fracture fixation sets
  • Intramedullary nails (specific to foot and ankle applications)
• Foot & Ankle (F&A) Reconstruction
  • Hallux Valgus / Bunion Correction
  • Hammertoe Correction
  • Midfoot Reconstruction
  • Hindfoot & Ankle Recon
  • Total Ankle Replacement (TAR)
  • Toe Joint Replacement
• Foot & Ankle (F&A) Orthobiologics
  • Biologics
  • Wedges
• Foot & Ankle (F&A) Soft Tissue Repair
  • Lateral ligament reconstruction
  • Achilles tendon repairs
  • Spring ligament and deltoid repair
  • Plantar plate repair systems
  • Flexor/extensor tendon augmentation
  • Soft tissue augmentation scaffolds
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Spain
  • Italy
  • France
  • Denmark
  • Norway
  • Sweden
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Application outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Foot And Ankle Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Advancements in Foot and Ankle Care in Europe: Technology, Patient-Centric Models, and Research Innovation
  • 3.3.1. Technological Advancements in Foot & Ankle
    • 3.3.1.1. Robotics and Computer Navigation
    • 3.3.1.2. Artificial Intelligence (AI)
    • 3.3.1.3. Advanced Imaging Techniques
    • 3.3.1.4. 3D Printing and Personalized Implants
    • 3.3.1.5. Biologics and Regenerative Medicine
    • 3.3.1.6. Minimally Invasive and Patient-Centric Care
    • 3.3.1.7. Enhanced Rehabilitation Models
    • 3.3.1.8. Digital Health and Wearables
• 3.4. Foot And Ankle Devices: Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
  • 3.4.2. PESTLE Analysis

Chapter 4. Foot And Ankle Devices Market Segment Analysis, By Application, 2021-2033 (USD Million)

• 4.1. Definition and Scope
• 4.2. Application Market Share Analysis, 2024 & 2033
• 4.3. Segment Dashboard
• 4.4. Global Foot And Ankle Devices Market, by Application, 2021 to 2033
• 4.5. Trauma
  • 4.5.1. Trauma market estimates and forecasts, 2021-2033 (USD Million)
  • 4.5.2. Ankle trauma
    • 4.5.2.1. Ankle trauma market estimates and forecasts, 2021-2033 (USD Million)
  • 4.5.3. Fibula fixation and syndesmosis repair systems
    • 4.5.3.1. Fibula fixation and syndesmosis repair systems market estimates and forecasts, 2021-2033 (USD Million)
  • 4.5.4. Talus and calcaneus trauma plates
    • 4.5.4.1. Talus and calcaneus trauma plates market estimates and forecasts, 2021-2033 (USD Million)
  • 4.5.5. Pilon fracture fixation sets
    • 4.5.5.1. Pilon fracture fixation sets market estimates and forecasts, 2021-2033 (USD Million)
  • 4.5.6. Intramedullary nails
    • 4.5.6.1. Intramedullary nails market estimates and forecasts, 2021-2033 (USD Million)
• 4.6. Reconstruction (Recon)
  • 4.6.1. Reconstruction (Recon) market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.2. Hallux valgus / Bunion correction
    • 4.6.2.1. Hallux valgus / Bunion correction market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.3. Hammertoe correction
    • 4.6.3.1. Hammertoe correction market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.4. Midfoot reconstruction
    • 4.6.4.1. Midfoot reconstruction market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.5. Hindfoot & Ankle recon
    • 4.6.5.1. Hindfoot & Ankle recon market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.6. Total Ankle Replacement (TAR)
    • 4.6.6.1. Total Ankle Replacement (TAR) market estimates and forecasts, 2021-2033 (USD Million)
  • 4.6.7. Toe joint replacement
    • 4.6.7.1. Toe joint replacement market estimates and forecasts, 2021-2033 (USD Million)
• 4.7. Orthobiologics
  • 4.7.1. Orthobiologics market estimates and forecasts, 2021-2033 (USD Million)
  • 4.7.2. Biologics
    • 4.7.2.1. Biologics market estimates and forecasts, 2021-2033 (USD Million)
  • 4.7.3. Wedges
    • 4.7.3.1. Wedges market estimates and forecasts, 2021-2033 (USD Million)
• 4.8. Soft Tissue Repair
  • 4.8.1. Soft tissue repair market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.2. Lateral ligament reconstruction
    • 4.8.2.1. Lateral ligament reconstruction market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.3. Achilles tendon repairs
    • 4.8.3.1. Achilles tendon repairs market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.4. Spring ligament and deltoid repair
    • 4.8.4.1. Spring ligament and deltoid repair market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.5. Plantar plate repair systems
    • 4.8.5.1. Plantar plate repair systems market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.6. Flexor/extensor tendon augmentation
    • 4.8.6.1. Flexor/extensor tendon augmentation market estimates and forecasts, 2021-2033 (USD Million)
  • 4.8.7. Soft tissue augmentation scaffolds
    • 4.8.7.1. Soft tissue augmentation scaffolds market estimates and forecasts, 2021-2033 (USD Million)

Chapter 5. Foot And Ankle Devices Market Segment Analysis, By Region, 2021- 2033 (USD Million)

• 5.1. Regional Market Share Analysis, 2024 & 2033
• 5.2. Regional Market Dashboard
• 5.3. Regional Market Snapshot
• 5.4. Foot And Ankle Devices Market Share by Region, 2024 & 2033:
• 5.5. North America
  • 5.5.1. North America foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. U.S. foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key country dynamics
    • 5.5.3.2. Regulatory framework
    • 5.5.3.3. Competitive scenario
    • 5.5.3.4. Canada foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key country dynamics
    • 5.5.4.2. Regulatory framework
    • 5.5.4.3. Competitive scenario
    • 5.5.4.4. Mexico foot and ankle devices market, 2021 - 2033 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key country dynamics
    • 5.6.2.2. Regulatory framework
    • 5.6.2.3. Competitive scenario
    • 5.6.2.4. UK foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key country dynamics
    • 5.6.3.2. Regulatory framework
    • 5.6.3.3. Competitive scenario
    • 5.6.3.4. Germany foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key country dynamics
    • 5.6.4.2. Regulatory framework
    • 5.6.4.3. Competitive scenario
    • 5.6.4.4. France foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key country dynamics
    • 5.6.5.2. Regulatory framework
    • 5.6.5.3. Competitive scenario
    • 5.6.5.4. Italy foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key country dynamics
    • 5.6.6.2. Regulatory framework
    • 5.6.6.3. Competitive scenario
    • 5.6.6.4. Spain foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.7. Norway
    • 5.6.7.1. Key country dynamics
    • 5.6.7.2. Regulatory framework
    • 5.6.7.3. Competitive scenario
    • 5.6.7.4. Norway foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key country dynamics
    • 5.6.8.2. Regulatory framework
    • 5.6.8.3. Competitive scenario
    • 5.6.8.4. Sweden foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.6.9. Denmark
    • 5.6.9.1. Key country dynamics
    • 5.6.9.2. Regulatory framework
    • 5.6.9.3. Competitive scenario
    • 5.6.9.4. Denmark foot and ankle devices market, 2021 - 2033 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Japan
    • 5.7.1.1. Key country dynamics
    • 5.7.1.2. Regulatory framework
    • 5.7.1.3. Competitive scenario
    • 5.7.1.4. Japan foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.7.2. China
    • 5.7.2.1. Key country dynamics
    • 5.7.2.2. Regulatory framework
    • 5.7.2.3. Competitive scenario
    • 5.7.2.4. China foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.7.3. India
    • 5.7.3.1. Key country dynamics
    • 5.7.3.2. Regulatory framework
    • 5.7.3.3. Competitive scenario
    • 5.7.3.4. India foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.7.4. Australia
    • 5.7.4.1. Key country dynamics
    • 5.7.4.2. Regulatory framework
    • 5.7.4.3. Competitive scenario
    • 5.7.4.4. Australia foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key country dynamics
    • 5.7.5.2. Regulatory framework
    • 5.7.5.3. Competitive scenario
    • 5.7.5.4. South Korea foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.7.6. Thailand
    • 5.7.6.1. Key country dynamics
    • 5.7.6.2. Regulatory framework
    • 5.7.6.3. Competitive scenario
    • 5.7.6.4. Thailand foot and ankle devices market, 2021 - 2033 (USD Million)
• 5.8. Latin America
  • 5.8.1. Brazil
    • 5.8.1.1. Key country dynamics
    • 5.8.1.2. Regulatory framework
    • 5.8.1.3. Competitive scenario
    • 5.8.1.4. Brazil foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.8.2. Argentina
    • 5.8.2.1. Key country dynamics
    • 5.8.2.2. Regulatory framework
    • 5.8.2.3. Competitive scenario
    • 5.8.2.4. Argentina foot and ankle devices market, 2021 - 2033 (USD Million)
• 5.9. MEA
  • 5.9.1. South Africa
    • 5.9.1.1. Key country dynamics
    • 5.9.1.2. Regulatory framework
    • 5.9.1.3. Competitive scenario
    • 5.9.1.4. South Africa foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.9.2. Saudi Arabia
    • 5.9.2.1. Key country dynamics
    • 5.9.2.2. Regulatory framework
    • 5.9.2.3. Competitive scenario
    • 5.9.2.4. Saudi Arabia foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.9.3. UAE
    • 5.9.3.1. Key country dynamics
    • 5.9.3.2. Regulatory framework
    • 5.9.3.3. Competitive scenario
    • 5.9.3.4. UAE foot and ankle devices market, 2021 - 2033 (USD Million)
  • 5.9.4. Kuwait
    • 5.9.4.1. Key country dynamics
    • 5.9.4.2. Regulatory framework
    • 5.9.4.3. Competitive scenario
    • 5.9.4.4. Kuwait foot and ankle devices market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company Categorization
• 6.3. Company Profiles
  • 6.3.1. Stryker Corporation
    • 6.3.1.1. Company overview
    • 6.3.1.2. Financial performance
    • 6.3.1.3. Product benchmarking
    • 6.3.1.4. Strategic initiatives
  • 6.3.2. Johnson & Johnson (De PuySynthes)
    • 6.3.2.1. Company overview
    • 6.3.2.2. Financial performance
    • 6.3.2.3. Product benchmarking
    • 6.3.2.4. Strategic initiatives
  • 6.3.3. Zimmer Biomet
    • 6.3.3.1. Company overview
    • 6.3.3.2. Financial performance
    • 6.3.3.3. Product benchmarking
    • 6.3.3.4. Strategic initiatives
  • 6.3.4. Smith+Nephew
    • 6.3.4.1. Company overview
    • 6.3.4.2. Financial performance
    • 6.3.4.3. Product benchmarking
    • 6.3.4.4. Strategic initiatives
  • 6.3.5. Bioventus LLC
    • 6.3.5.1. Company overview
    • 6.3.5.2. Financial performance
    • 6.3.5.3. Product benchmarking
    • 6.3.5.4. Strategic initiatives
  • 6.3.6. Enovis Corp.
    • 6.3.6.1. Company overview
    • 6.3.6.2. Financial performance
    • 6.3.6.3. Product benchmarking
    • 6.3.6.4. Strategic initiatives
  • 6.3.7. Acumed LLC
    • 6.3.7.1. Company overview
    • 6.3.7.2. Financial performance
    • 6.3.7.3. Product benchmarking
    • 6.3.7.4. Strategic initiatives
  • 6.3.8. Arthrex, Inc.
    • 6.3.8.1. Company overview
    • 6.3.8.2. Financial performance
    • 6.3.8.3. Product benchmarking
    • 6.3.8.4. Strategic initiatives
  • 6.3.9. Anika Therapeutics, Inc
    • 6.3.9.1. Company overview
    • 6.3.9.2. Financial performance
    • 6.3.9.3. Product benchmarking
    • 6.3.9.4. Strategic initiatives
  • 6.3.10. Orthofix, Inc.
    • 6.3.10.1. Company overview
    • 6.3.10.2. Financial performance
    • 6.3.10.3. Product benchmarking
    • 6.3.10.4. Strategic initiatives
  • 6.3.11. Globus Medical
    • 6.3.11.1. Company overview
    • 6.3.11.2. Financial performance
    • 6.3.11.3. Product benchmarking
    • 6.3.11.4. Strategic initiatives
  • 6.3.12. CONMED Corporation
    • 6.3.12.1. Company overview
    • 6.3.12.2. Financial performance
    • 6.3.12.3. Product benchmarking
    • 6.3.12.4. Strategic initiatives